Click Here for 5% Off Your First Aladdin Purchase!

4-[4-[[(3R)-3-methyl-4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]methyl]-1H-pyrazol-5-yl]benzonitrile , CAS No.R610620, Inhibitor of IP 3 kinase A;Inhibitor of IP 3 kinase B;Inhibitor of IP 3 kinase C

  • Moligand™
Item Number
R610620
Grouped product items
SKUSizeAvailabilityPrice Qty
R610620-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$277.90
R610620-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,108.90

Basic Description

Synonymsexample 71 [US20090306039]
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of IP 3 kinase A;Inhibitor of IP 3 kinase B;Inhibitor of IP 3 kinase C

Associated Targets

ITPKA Tchem Inositol-trisphosphate 3-kinase A 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ITPKB Tchem Inositol-trisphosphate 3-kinase B 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ITPKC Tchem Inositol-trisphosphate 3-kinase C 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 4-[4-[[(3R)-3-methyl-4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]methyl]-1H-pyrazol-5-yl]benzonitrile
INCHI InChI=1S/C22H21F3N6/c1-15-13-30(8-9-31(15)20-7-6-19(12-27-20)22(23,24)25)14-18-11-28-29-21(18)17-4-2-16(10-26)3-5-17/h2-7,11-12,15H,8-9,13-14H2,1H3,(H,28,29)/t15-/m1/s1
InChi Key VNTCGXMLDSKOKN-OAHLLOKOSA-N
Canonical SMILES N#Cc1ccc(cc1)c1n[nH]cc1CN1CCN([C@@H](C1)C)c1ccc(cn1)C(F)(F)F
Isomeric SMILES C[C@@H]1CN(CCN1C2=NC=C(C=C2)C(F)(F)F)CC3=C(NN=C3)C4=CC=C(C=C4)C#N
PubChem CID 57999583

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Miller AT, Dahlberg C, Sandberg ML, Wen BG, Beisner DR, Hoerter JA, Parker A, Schmedt C, Stinson M, Avis J et al..  (2015)  Inhibition of the Inositol Kinase Itpkb Augments Calcium Signaling in Lymphocytes and Reveals a Novel Strategy to Treat Autoimmune Disease..  PLoS ONE,  10  (6): (e0131071).  [PMID:26121493]

Solution Calculators